Nursing Pharmacology:  Antiviral Drugs

Previous Page Page Forward
Section Table of Contents
Site Table of Contents
Previous Page Page Forward
Section Table of Contents
Site Table of Contents

References

  1. Flexner C Antiretroviral Agents and Treatment of HIV Infection, Chapter 59  in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th edition (Brunton LL Chabner BA Knollmann BC, eds; Brunton LL, ed; Blumenthal DK  Murri N Hilal-Dandan R, assoc eds, Knollmann BC, consulting ed, on-line edition) The McGraw-Hill Companies, 2011.

  2. Fauci AS Lane HC Chapter 226, Human Immunodeficiency Virus Disease:  AIDS and Related Disorders, in Harrison's Online   (Kasper DL Fauci AS Hauser SL Longo DL Jameson JL Loscalzo J, Eds.),  Harrison's Principles of Internal Medicine, 19th edition, The McGraw-Hill Companies, Inc. 2015 (on-line edition)

  3. Longo DL Fauci AS  188, The Human Retroviruses, in Harrison's Online   (Dan L. Longo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, J. Larry Jameson, Joseph Loscalzo, Eds.),  Harrison's Principles of Internal Medicine, 18th edition, The McGraw-Hill Companies, Inc. 2012.

  4. Woster PM Chapter 43:  Antiviral Agents and Protease Inhibitors in Foye's Principles of Medicinal Chemistry 6e, Lemke, TL Williams DA, eds; Roche VG Zito SW, asst eds) Wolters Kluwer|Lippincott Williams & Wilkins 1214, 2008.

  5. HIV Overview:  The HIV Life Cycle, Education Materials, AIDSinfo, NIH http://aidsinfo.nih.gov/education-materials/fact-sheets/19/73/the-hiv-life-cycle

  6. Tsibris AMN Hirsch MS Chapter 130 Antiretroviral Therapy for Human Immunodeficiency Virus Infection in Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8e (Bennett JE Bolin R Blaser, eds) Elsevier, Inc/Saunders 2015, online version.

  7. Safrin S Chapter 49:  Antiviral Agents:  Antiretroviral Agents in Basic & Clinical Pharmacology 13e (Katzung BG Trevor AJ, eds) 2015, online edition.

  8. HIV Overview:  The HIV Life Cycle, Education Materials, AIDSinfo, NIH http://aidsinfo.nih.gov/education-materials/fact-sheets/19/73/the-hiv-life-cycle

  9. Wensing AM Calvez V Gunthard JF Johnson VA Paredes R Pillay D Shafer RW Richman DD Special Contribution:  2014 Update of the Drug Resistance Multations in HIV-1 Topics in Antivral Medicine 22(3)  June/July 2014, https://www.iasusa.org/sites/default/files/tam/22-3-642.pdf

  10. Perry CM Faulds D Lamivudine:  A Review of its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy in the Management of HIV Infection.  Drugs 53(4):  667-68- 1997. http://www.ncbi.nlm.nih.gov/pubmed/9098665

  11. Wainberg MA Miller MD Quan Y Salomon H Mulato AS Lamy PD Margot NA Anton KE Cherrington JM In vitro selection and charactization of HIV-1 with reduced susceptibility to PMPA.  Antiviral Therapy 4:  87-94 1999. http://www.ncbi.nlm.nih.gov/pubmed/10682153 (second sourced from reference 1)

  12. Larder BA Kemp SD Harrigan PR Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy. Science, New Series, 269(5334) pp 696-699, Aug. 4, 1995. http://www.ncbi.nlm.nih.gov/pubmed/7542804 (second sourced from reference 1)

  13. Jayasekara D Aweeka FT Rodriguez R Kalayjian RC Humphreys MH Gambertoglio JB Antiviral Therapy for HIV Patients with Renal Insufficiency JAIDS, Journal of Acquied Immune Deficiency Syndromes 21:  384-395 1999. http://www.ncbi.nlm.nih.gov/pubmed/10458619  (second sourced from reference 1)

line-height: 200%